INTERNATIONAL PATENT: HEROPHILUS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS RELATED TO MODULATING MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-CD74 SIGNALING AND RELATED TREATMENTS FOR NEUROINFLAMMATORY CONDITIONS"

GENEVA, Aug. 19 -- HEROPHILUS, INC. (1405 Minnesota StreetSan Francisco, CA 94107) filed a patent application (PCT/US2025/015312) for "COMPOSITIONS AND METHODS RELATED TO MODULATING MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-CD74 SIGNALING AND RELATED TREATMENTS FOR NEUROINFLAMMATORY CONDITIONS" on Feb 10, 2025. With publication no. WO/2025/171411, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHAH, Kevan (Herophilus, Inc.1405 Minnesota StreetSan Francisco, CA 94107), RAO, Sneha (Herophilus, Inc.1405 Minnesota StreetS...